Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease

  • Baek, Jin-Young (Department of Pediatrics, Good GangAn Hospital) ;
  • Song, Min Seob (Department of Pediatrics, Inje University Haeundae Paik Hospital, Inje University College of Medicine)
  • Received : 2015.06.05
  • Accepted : 2015.07.20
  • Published : 2016.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Studies have been conducted to identify predictive factors of resistance to intravenous immunoglobulin (IVIG) for Kawasaki disease (KD). However, the results are conflicting. This study aimed to identify laboratory factors predictive of resistance to high-dose IVIG for KD by performing meta-analysis of available studies using statistical techniques. Methods: All relevant scientific publications from 2006 to 2014 were identified through PubMed searches. For studies in English on KD and IVIG resistance, predictive factors were included. A meta-analysis was performed that calculated the effect size of various laboratory parameters as predictive factors for IVIG-resistant KD. Results: Twelve studies comprising 2,745 patients were included. Meta-analysis demonstrated significant effect sizes for several laboratory parameters: polymorphonuclear leukocytes (PMNs) 0.698 (95% confidence interval [CI], 0.469-0.926), C-reactive protein (CRP) 0.375 (95% CI, 0.086-0.663), pro-brain natriuretic peptide (pro-BNP) 0.561 (95% CI, 0.261-0.861), total bilirubin 0.859 (95% CI, 0.582-1.136), alanine aminotransferase (AST) 0.503 (95% CI, 0.313-0.693), aspartate aminotransferase (ALT) 0.436 (95% CI, 0.275-0.597), albumin 0.427 (95% CI, -0.657 to -0.198), and sodium 0.604 (95% CI, -0.839 to -0.370). Particularly, total bilirubin, PMN, sodium, pro-BNP, and AST, in descending numerical order, demonstrated more than a medium effect size. Conclusion: Based on the results of this study, laboratory predictive factors for IVIG-resistant KD included higher total bilirubin, PMN, pro-BNP, AST, ALT, and CRP, and lower sodium and albumin. The presence of several of these predictive factors should alert clinicians to the increased likelihood that the patient may not respond adequately to initial IVIG therapy.

Keywords

References

  1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78
  2. Lee SM, Lee JB, Go YB, Song HY, Lee BJ, Kwak JH. Prediction of resistance to standard intravenous immunoglobulin therapy in Kawasaki disease. Korean Circ J 2014;44:415-22. https://doi.org/10.4070/kcj.2014.44.6.415
  3. Cho KH, Kang SJ. Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete Kawasaki disease. Korean Circ J 2014;44:328-35. https://doi.org/10.4070/kcj.2014.44.5.328
  4. Sato S, Kawashima H, Kashiwagi Y, Hoshika A. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis 2013;16:168-72. https://doi.org/10.1111/1756-185X.12082
  5. Fu PP, Du ZD, Pan YS. Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J 2013;32:e319-23.
  6. Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. J Pediatr 2013;162:1205-9. https://doi.org/10.1016/j.jpeds.2012.11.026
  7. Park HM, Lee DW, Hyun MC, Lee SB. Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease. Korean J Pediatr 2013;56:75-9. https://doi.org/10.3345/kjp.2013.56.2.75
  8. Kim HK, Oh J, Hong YM, Sohn S. Parameters to guide retreatment after initial intravenous immunoglobulin therapy in Kawasaki disease. Korean Circ J 2011;41:379-84. https://doi.org/10.4070/kcj.2011.41.7.379
  9. Do YS, Kim KW, Chun JK, Cha BH, Namgoong MK, Lee HY. Predicting factors for refractory Kawasaki disease. Korean Circ J 2010;40:239-42. https://doi.org/10.4070/kcj.2010.40.5.239
  10. Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 2010;99:1578-83. https://doi.org/10.1111/j.1651-2227.2010.01875.x
  11. Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 2011;158:831-5.e3. https://doi.org/10.1016/j.jpeds.2010.10.031
  12. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of non-responsiveness to standard high-dose gamma -globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 2007;166:131-7.
  13. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12. https://doi.org/10.1161/CIRCULATIONAHA.105.592865
  14. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 2008;153:117-21. https://doi.org/10.1016/j.jpeds.2007.12.021
  15. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates, 1988:273-406.

Cited by

  1. Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease vol.59, pp.12, 2016, https://doi.org/10.3345/kjp.2016.59.12.477
  2. Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease vol.8, pp.31, 2016, https://doi.org/10.18632/oncotarget.17700
  3. Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 20 vol.48, pp.1, 2016, https://doi.org/10.4070/kcj.2017.0136
  4. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases vol.177, pp.8, 2018, https://doi.org/10.1007/s00431-018-3182-2
  5. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing vol.104, pp.3, 2016, https://doi.org/10.1136/archdischild-2017-314512
  6. Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease vol.62, pp.4, 2016, https://doi.org/10.3345/kjp.2018.07052
  7. Predictive risk factors of coronary artery aneurysms in Kawasaki disease vol.62, pp.4, 2019, https://doi.org/10.3345/kjp.2019.00073
  8. Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease vol.62, pp.4, 2016, https://doi.org/10.3345/kjp.2019.00150
  9. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm vol.19, pp.2, 2016, https://doi.org/10.1007/s10238-018-00544-5
  10. Clinical Significance of Late Onset Arthritis in Kawasaki Disease vol.29, pp.3, 2016, https://doi.org/10.5812/ijp.84506
  11. Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease vol.99, pp.6, 2016, https://doi.org/10.1097/md.0000000000018535
  12. The role of corticosteroids in the treatment of Kawasaki disease vol.18, pp.2, 2016, https://doi.org/10.1080/14787210.2020.1713752
  13. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease vol.19, pp.4, 2016, https://doi.org/10.3892/etm.2020.8519
  14. Usefulness of Kawasaki disease risk scoring systems to the Turkish population vol.24, pp.2, 2020, https://doi.org/10.14744/anatoljcardiol.2020.37560
  15. A novel score system of blood tests for differentiating Kawasaki disease from febrile children vol.16, pp.1, 2016, https://doi.org/10.1371/journal.pone.0244721